Modip (Felodipine)

Felodipine, the active ingredient in Modip, is a calcium channel blocker presented as an oral tablet for oral use. It treats hypertension and chronic stable angina in adult patients.

GNH USA supplies Modip as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Felodipine is used to manage cardiovascular conditions that involve elevated arterial pressure or reduced coronary blood flow. - Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Chronic stable angina: improves myocardial oxygen supply by dilating coronary arteries, decreasing frequency of chest pain episodes.

Adverse reactions may occur with felodipine therapy.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Flushing: warm sensation, usually on the face or neck. - Peripheral edema: swelling of ankles or feet. - Dizziness or light‑headedness, especially upon standing. - Nausea or abdominal discomfort. - Tachycardia: increased heart rate.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Myocardial infarction: rare but possible in high‑risk patients. - Allergic reactions: rash, itching, or anaphylaxis. - Hepatic dysfunction: elevated liver enzymes. - Blood dyscrasias: leukopenia or thrombocytopenia. - Cardiac arrhythmias: irregular heart rhythms.

Patients should be monitored for safety and appropriate use of felodipine. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Hepatic function assessment: evaluate liver enzymes before initiating therapy. - Elderly caution: start with lower doses due to increased sensitivity. - Concomitant antihypertensives: adjust doses to prevent additive blood pressure lowering. - Discontinuation: avoid abrupt cessation to reduce rebound hypertension risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Felodipine may interact with several medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase felodipine plasma levels. - CYP3A4 inducers (e.g., rifampicin, carbamazepine): reduce therapeutic effect. - Grapefruit juice: can markedly raise felodipine concentrations.

Moderate Interactions (Monitor Closely):\n- Beta‑blockers: additive blood pressure lowering. - Diuretics: may enhance orthostatic hypotension. - NSAIDs: can blunt antihypertensive response. - Alcohol: may increase dizziness and hypotension. - Other calcium channel blockers: risk of excessive vasodilation.